Related Experiment Videos
The case for metabolic hypertension: is it time to restructure the hypertension paradigm?
1North County Cardiology Research Laboratory, Encinitas, CA 92024.
Progress in Cardiovascular Diseases
|July 1, 1993
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Does Chinese ethnicity affect the pharmacokinetics and pharmacodynamics of angiotensin-converting enzyme inhibitors?
Journal of human hypertension·2000
Anomalies in the dosing of diltiazem.
Clinical cardiology·2000
The clinical significance of neurohormonal activation.
Clinical therapeutics·1997
Aficamten is associated with improvements in cardiac mechanics in obstructive hypertrophic cardiomyopathy: Results from FOREST-HCM.
Progress in cardiovascular diseases·2026
Joint associations of Interleukin-6 and apolipoprotein B with major adverse cardiovascular events in the UK biobank.
Progress in cardiovascular diseases·2026
Obesity, lipids, inflammation, and healthy aging.
Progress in cardiovascular diseases·2026
Revascularization options for managing patients with multi-vessel coronary artery disease.
Progress in cardiovascular diseases·2026
Predictivity of preoperative weight loss on co-morbidity resolution in bariatric patients.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2026
Circulating Biomarkers Related to Mitral Valve Prolapse: Current Evidence and Mechanistic Perspective.
Current cardiology reports·2026
Aging Reprograms the Signaling, Metabolic, and Gene Regulatory Dynamics in Murine Bone Marrow-Derived Mesenchymal Stem Cells.
Applied sciences (Basel, Switzerland)·2026